Economic Evaluation of Heart Failure Management in Colombian Clinics

AstraZeneca0 sites300 target enrollmentJanuary 2008

ConditionsHeart Failure Asthma

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Heart Failure
Sponsor: AstraZeneca
Enrollment: 300
Primary Endpoint: To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia
Status: Completed
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.

Registry

clinicaltrials.gov

Start Date

January 2008

End Date

June 2008

Last Updated

16 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

AstraZeneca

Eligibility Criteria

Inclusion Criteria

•Asthma moderate to severe.

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia

Time Frame: 12 months

Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives